• July 24, 2024

FDA Gives A Nod To Descovy, A Combination Of Drug To Prevent HIV

Gilead Sciences Inc’s Descovy has been approved by FDA on Wednesday. It is a combination drug used to reduce the risks of HIV in men and in transgender women having sex with men. Descovy is the combination of tenofovir alafenamide and emtricitabine and has been approved for the treatment of chronic HIV. To assess Descovy’s…

Read More